PMID- 24158501 OWN - NLM STAT- MEDLINE DCOM- 20150219 LR - 20211021 IS - 1432-2072 (Electronic) IS - 0033-3158 (Linking) VI - 231 IP - 5 DP - 2014 Mar TI - MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density. PG - 863-74 LID - 10.1007/s00213-013-3304-5 [doi] AB - OBJECTIVES: Addictive drugs produce forms of structural plasticity in the nucleus accumbens and prefrontal cortex. The aim of this study was to investigate the impact of chronic MDMA exposure on pyramidal neurons in the CA1 region of hippocampus and drug-related spatial learning and memory changes. METHODS AND RESULTS: Adolescent rats were exposed to saline or MDMA in a regime that mimicked chronic administration. One week later, when acquisition or reference memory was evaluated in a standard Morris water maze (MWM), no differences were obtained between groups. However, MDMA-exposed animals performed better when the MWM was implemented under more difficult conditions. Animals of MDMA group were less anxious and were more prepared to take risks, as in the open field test they ventured more frequently into the central area. We have demonstrated that MDMA caused an increase in brain-derived neurotrophic factor (BDNF) expression. When spine density was evaluated, MDMA-treated rats presented a reduced density when compared with saline, but overall, training increased the total number of spines, concluding that in MDMA-group, training prevented a reduction in spine density or induced its recovery. CONCLUSIONS: This study provides support for the conclusion that binge administration of MDMA, known to be associated to neurotoxic damage of hippocampal serotonergic terminals, increases BDNF expression and stimulates synaptic plasticity when associated with training. In these conditions, adolescent rats perform better in a more difficult water maze task under restricted conditions of learning and memory. The effect on this task could be modulated by other behavioural changes provoked by MDMA. FAU - Abad, Sonia AU - Abad S AD - Department of Pharmacology and Therapeutic Chemistry (Pharmacology Section) and Institute of Biomedicine (IBUB), University of Barcelona, Avda. Joan XXIII s/n, Barcelona, 08028, Spain. FAU - Fole, Alberto AU - Fole A FAU - del Olmo, Nuria AU - del Olmo N FAU - Pubill, David AU - Pubill D FAU - Pallas, Merce AU - Pallas M FAU - Junyent, Felix AU - Junyent F FAU - Camarasa, Jorge AU - Camarasa J FAU - Camins, Antonio AU - Camins A FAU - Escubedo, Elena AU - Escubedo E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131026 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Body Temperature/drug effects MH - Body Weight/drug effects MH - CA1 Region, Hippocampal/cytology/*drug effects MH - Dendritic Spines/drug effects MH - Male MH - Maze Learning/drug effects MH - Memory/*drug effects MH - Memory Disorders/chemically induced MH - N-Methyl-3,4-methylenedioxyamphetamine/blood/*toxicity MH - Rats MH - Rats, Sprague-Dawley EDAT- 2013/10/26 06:00 MHDA- 2015/02/20 06:00 CRDT- 2013/10/26 06:00 PHST- 2013/06/18 00:00 [received] PHST- 2013/09/23 00:00 [accepted] PHST- 2013/10/26 06:00 [entrez] PHST- 2013/10/26 06:00 [pubmed] PHST- 2015/02/20 06:00 [medline] AID - 10.1007/s00213-013-3304-5 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2014 Mar;231(5):863-74. doi: 10.1007/s00213-013-3304-5. Epub 2013 Oct 26.